Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · IEX Real-Time Price · USD
6.89
+0.07 (1.03%)
At close: Jul 19, 2024, 4:00 PM
6.99
+0.10 (1.45%)
Pre-market: Jul 22, 2024, 7:44 AM EDT
Verve Therapeutics Market Cap
Verve Therapeutics has a market cap or net worth of $578.52 million as of July 22, 2024. Its market cap has decreased by -49.72% in one year.
Market Cap
578.52M
Enterprise Value
30.84M
1-Year Change
-49.72%
Ranking
Category
Stock Price
$6.89
Market Cap Chart
Since the IPO on June 17, 2021, Verve Therapeutics's market cap has decreased from $869.34M to $578.52M, a decrease of -33.45%. That is a compound annual growth rate of -12.35%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 578.50M | -34.90% |
Dec 29, 2023 | 888.70M | -25.44% |
Dec 30, 2022 | 1.19B | -32.89% |
Dec 31, 2021 | 1.78B | 104.31% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Allogene Therapeutics | 590.86M |
Applied Therapeutics | 587.33M |
Emergent BioSolutions | 586.90M |
Varex Imaging | 580.78M |
Orthofix Medical | 580.20M |
Pharming Group | 577.28M |
GH Research | 574.91M |
IRadimed | 572.42M |